Corporate Governance

INVESTORS RELATIONS

Giovanni Plasmati
[email protected]

Corporate Governance


Luciano Fecondini

PRESIDENT OF THE BOARD

After graduating in chemical engineering from the University of Bologna in 1972 at the age of 23, Luciano had a brief spell in the petrochemical industry before joining Dasco's BioMed R&D department, the European market leader at the time, together with Bellco. In 1980, Luciano became Head of Global R&D for hemofiltration at Amicon in Massachusetts, USA. In 1985, he returned to Italy and, together with Andrea Bocchi, founded Medica, initially as a research and development laboratory providing consultancy services to large multinational companies, and later as a true partner to the medical device manufacturing industry, having acquired expertise in electromedical equipment / automation with the acquisition of Tecnoideal in 1990.

Since then, Luciano has led the Medica Group into a pocket-sized multinational with world-class know-how in medical and water purification hollow fibre membranes and electromedical devices.

Luciano Fecondini was also President of the 'CONSOBIOMED Consortium', which brought together 24 Italian BioMed companies.



Marco Fecondini

CEO & BOARD MEMBER

After graduating in Agricultural Science from the University of Bologna in 2004 and obtaining a Master's degree in Horticultural Science from the Technical University of Munich, Marco continued his academic career with a PhD from the University of Bologna, while working as a consultant in Peru, Burkina Faso and Brazil on food safety programmes and simplified hydroponic systems.

Marco joined Medica in 2011, initially in R&D - single-use products for blood purification, then as business developer of the Water Division (from 2012 to May 2021) and as Director (since 2015).

As of 2023, Marco holds the position of CEO (Chief Executive Officer)




Letizia Bocchi

BOARD MEMBER

After graduating in Biotechnology from the University of Modena and Reggio Emilia in 2004, Letizia worked for a couple of years at Medica as a specialist in medical applications. She then completed her PhD in Biochemistry, Molecular Biology and Biotechnology at the University of Ferrara, while working as a research assistant on a project investigating cholesterol metabolism. In 2010, she returned to Medica and worked in R&D for 11 years, specialising in Membranes and Filters, managing:

  • Clinical trials: setting up and supervising a clinical trial of a biomedical device used for leukoapheresis treatments;
  • Laboratory: R&D Membranes and filters. Validation and performance tests on hollow fibre filters used for hemofiltration, dialysis, water purification;
  • Patent office and intellectual property management.

Since 2013, Letizia has been the Director and IP Manager and in 2021 she was appointed Head of the Research Laboratory.

Letizia is a board member of Mister Smart Innovation S.c.r.l.




Chiara Stancari

BOARD MEMBER

Administration Manager - Board Member

After graduating in Accounting at the ITC L. Einaudi in San Giovanni in Persiceto (BO), she held the position of Accounting & Administration Manager in various companies in the Bologna area, before joining Medica in 1995 as Administration Manager.

Chiara is a Member of the Board of Directors.



Andrea Moschetti

INDIPENDENT DIRECTOR




Anna Laura Mazza

PRESIDENT



Stefania Grazia

STATUTORY AUDITOR



Riccardo Vergnanini

STATUTORY AUDITOR



Loris Quattrini

ALTERNATE AUDITOR



Guerzoni Sandra

ALTERNATE AUDITOR


DownloadPDF Statute
DownloadPDF Procedure for related party transactions
DownloadPDF Internal dealing procedure
DownloadPDF Inside information procedure
DownloadPDF Communications to Euronext Growth Advisor procedure
DownloadPDF Procedure for defining the criteria for the evaluation of independent directors

The Board of Directors of Medica S.p.A. has adopted Italian Legislative Decree No. 231 of 8 June 2001 for the definition of the company's Organisational Models, which summarises the set of prevention rules and relative responsibilities for the prevention of the offences referred to in the Decree itself, consisting of a General Section and several Specific Sections.

The General Section illustrates:

  • the operating principles of Italian Leg. Decree 231/01
  • the procedures for its adoption and dissemination within the Company
  • the tasks of the Supervisory Board and the related information flows
  • the disciplinary system.

The Special Sections illustrate:

  • the detailed mapping of sensitive areas
  • examples of offences
  • conduct of and prohibitions of the recipients.

Among the Special Sections, the Code of Ethics sets out the standards of behaviour for managers and employees; compliance with the Code of Ethics is particularly important both for the proper functioning and reliability of the Company and for the protection of its prestige and image in day-to-day business.

DownloadPDF Organisational Models 
DownloadPDF Code of Ethics